Your session is about to expire
Olmesartan vs Losartan
Introduction
For patients with hypertension or other cardiovascular conditions, certain medications that can adjust the narrowing and widening of blood vessels, known as angiotensin receptor blockers (ARBs), can assist in managing high blood pressure and reducing potential complications. Olmesartan and Losartan are two such drugs prescribed for these conditions. They each impact different aspects of the body's response to angiotensin II — a hormone that causes constriction of blood vessels — but both have significant effects in maintaining optimal vascular health. Olmesartan is known for its long-acting antihypertensive property due to its strong binding affinity towards the angiotensin receptor. On the other hand, Losartan is not only an ARB but also has uricosuric effects which means it helps excrete uric acid through urine making it beneficial for patients with gouty arthritis.
Olmesartan vs Losartan Side By Side
| Attribute | Benicar | Cozaar |
|---|---|---|
| Brand Name | Benicar | Cozaar |
| Contraindications | Should not be taken with ACE inhibitors | Should not be taken with ACE inhibitors |
| Cost | Brand name: $125 for 30 tablets (20 mg), Generic: $10-$40 for 30 tablets (20mg) | Brand name: $100 for 30 tablets (50 mg), Generic: $.11-$0.75 per tablet (50mg) |
| Generic Name | Olmesartan | Losartan |
| Most Serious Side Effect | Signs of an allergic reaction, change in vision, rapid/slow/irregular heartbeats, shortness of breath, severe kidney problems, high potassium levels | Allergic reactions, kidney issues, fainting spells, rapid heartbeat, severe gastrointestinal problems, jaundice |
| Severe Drug Interactions | ACE inhibitors | ACE inhibitors |
| Typical Dose | 20-40 mg/day | 50-100 mg/day |
What is Olmesartan?
Olmesartan (marketed under the brand name Benicar) and Losartan (Cozaar) are both angiotensin II receptor blockers (ARBs), a class of drugs that emerged as an important development in the treatment of hypertension. Olmesartan was first approved by the FDA in 2002, some years after Losartan's approval in 1995. They work by blocking the action of angiotensin II, a hormone that can cause blood vessels to narrow, effectively relaxing and widening them for improved blood flow. Both drugs are prescribed mainly for treating high blood pressure but also show effectiveness against kidney disease from diabetes or heart failure. Olmesartan has been noted to be slightly more effective at lowering systolic blood pressure compared with Losartan; however, it may have more noticeable side effects including dizziness and increased creatinine levels.
What conditions is Olmesartan approved to treat?
Olmesartan is approved for the treatment of several conditions associated with hypertension:
- Essential hypertension, also known as primary high blood pressure
- Cardiovascular risk reduction in patients unable to take ACE inhibitors
- Hypertension occurring alongside other cardiovascular diseases.
How does Olmesartan help with these illnesses?
Olmesartan works to manage high blood pressure by blocking the action of a hormone in the body known as angiotensin II. Angiotensin II is a potent vasoconstrictor, which means it causes the blood vessels to narrow and thereby increases blood pressure. Olmesartan does this by binding with angiotensin receptors in many tissues and inhibits or blocks its actions, so levels can be maintained lower for longer periods of time. Angiotensin II plays an important role in maintaining blood volume and systemic vascular resistance, influencing cardiac contractility, among other things. It is thought that individuals with hypertension have relatively higher activity of this system. Therefore, by inhibiting angiotensin II's effects through receptor blockade, Olmesartan helps limit the negative effects of hypertension and assists patients maintain their condition and stabilize their blood pressure.
What is Losartan?
Losartan, also known under the brand name Cozaar, is an angiotensin II receptor antagonist that helps to reduce blood pressure by relaxing and widening the blood vessels. It was first approved by the FDA in 1995. Losartan works differently than ACE inhibitors like olmesartan as it does not inhibit the action of an enzyme (angiotensin-converting enzyme) but directly blocks a specific receptor (type 1 angiotensin II receptor). This means its side-effect profile may be different from that of ACE inhibitors. Notably, losartan is less likely to cause persistent dry cough - a common side effect associated with ACE inhibitors such as olmesartan. The effects on angiotensin II receptors can help manage hypertension and could be beneficial for patients who do not respond well or have had adverse reactions to ACE inhibitors.
What conditions is Losartan approved to treat?
Losartan is an angiotensin receptor blocker (ARB) that has been approved by the FDA for treating a variety of health conditions, such as:
- Hypertension, commonly known as high blood pressure
- Stroke risk reduction in patients with hypertension and left ventricular hypertrophy
- Diabetic nephropathy: Losartan is used to protect the kidneys from damage due to diabetes.
How does Losartan help with these illnesses?
Angiotensin II is a hormone that plays an important role in regulating blood pressure. It causes the arteries to narrow (vasoconstriction) and promotes the release of another hormone called aldosterone, leading to increased volume of circulating blood and subsequently increasing blood pressure. Losartan works by blocking the action of angiotensin II, helping to relax and widen the blood vessels, thus lowering high blood pressure effectively. This mechanism also aids in protecting kidneys from damage, particularly beneficial for diabetic patients. Although Olmesartan belongs to the same class of drugs as Losartan known as angiotensin receptor blockers (ARBs), differences exist between them including their duration of action and potential side effects profile. For instance, Losartan may be preferred over Olmesartan because it has additional benefits for patients with certain heart conditions due its unique metabolite.
How effective are both Olmesartan and Losartan?
Both olmesartan and losartan are angiotensin II receptor blockers (ARBs) with established histories of effectiveness in treating hypertension. They were approved by the FDA within 3 years of each other, with losartan receiving approval in 1995 and olmesartan in 2002. Both drugs act on the renin-angiotensin-aldosterone system, but they may be prescribed under differing circumstances due to varying patient characteristics.
The two drugs' efficacy was compared directly in a double-blind clinical trial conducted in 2001; both exhibited similar capabilities at reducing blood pressure levels and had comparable safety profiles. In this study, there were no significant differences between patients taking either drug regarding changes measured for systolic or diastolic pressure.
A meta-analysis review from 2007 indicated that olmesartan is effective at lowering blood pressure beginning from the first week of treatment and has a side effect profile comparable to placebo. The same study concluded that olmesartan might offer superior blood-pressure-lowering efficacy compared to some other ARBs, including losartan.
On the other hand, a review published in 2010 suggested that while losartan effectively reduces blood pressure similarly to other common ARBs, it also provides additional benefits such as renal protection which can make it an optimal choice for certain patient groups such as those suffering from diabetic nephropathy.
Overall though, selecting between these two medications often comes down to individual patient factors rather than clear-cut superiority of one drug over another.
Related trials for olmesartan and losartan
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Olmesartan typically prescribed?
Oral dosages of Olmesartan typically range from 20-40 mg/day for adults, but studies have shown that a starting dose of 20 mg/day is effective in treating high blood pressure for most people. Children and adolescents may be started on a lower dosage as prescribed by the doctor. If there is no response after two weeks, the dosage can be increased gradually under medical supervision. However, the maximum dosage that should not be exceeded in any case is 40 mg/day.
At what dose is Losartan typically prescribed?
Losartan therapy for hypertension typically starts at a dosage of 50 mg per day. The dose can then be increased to 100 mg/day, given as one single dose or divided into two doses spaced 12 hours apart. If blood pressure isn't adequately controlled after several weeks, the maximum recommended daily dosage is 100 mg taken once daily. Alternatively, other antihypertensive drugs may be added to further control blood pressure if needed. It's important that Losartan is taken consistently at the same time each day and monitored regularly by your healthcare provider to ensure optimal treatment outcomes.
What are the most common side effects for Olmesartan?
Common side effects patients might experience while taking olmesartan include:
- Dizziness or lightheadedness as your body adjusts to the medication
- A change in the amount of urine produced
- Unusual tiredness or weakness, signs of a high potassium blood level (such as muscle weakness, slow/irregular heartbeat)
- Signs of kidney problems (such as change in the amount of urine)
On the other hand, common side effects associated with losartan are:
- Lightheadedness and dizziness due to lower blood pressure
- Stomach pain
- Fatigue
- Coughing
- Diarrhea
Both medications may cause serious consequences if not taken under proper medical guidance. Always consult your healthcare provider before starting any new medication.
Are there any potential serious side effects for Olmesartan?
Both Olmesartan and Losartan are generally well tolerated, but they can cause side effects in rare cases. These may include:
- Signs of an allergic reaction such as hives, difficulty breathing or swallowing, swelling of the face or throat
- A change in vision or eye pain
- Rapid, slow or irregular heartbeats
- Shortness of breath or trouble breathing
- Lightheadedness, dizziness or fainting spells
More severe symptoms related to kidney problems might also occur. These could be indicated by changes in the frequency of urination, nausea and vomiting, swelling of the extremities (feet and hands), fatigue or weakness.
There's also a risk for high potassium levels which can result in muscle weakness/paralysis, abnormal heart rhythms and tingling sensations.
If you experience any serious side effects while taking these medications contact your doctor immediately.
What are the most common side effects for Losartan?
Some of the common side effects that you might experience with Losartan include:
- Dizziness or lightheadedness due to a drop in blood pressure
- Stomach pain, nausea, diarrhea or constipation
- Muscle cramps or muscle weakness
- Unusual tiredness and fatigue
- A stuffy nose, sore throat, coughing, or sinus congestion
- Swelling in your legs, ankles, hands or feet (edema)
- Sleep problems such as insomnia In rare cases:
- Irregular heartbeat -Hives and skin rash
Are there any potential serious side effects for Losartan?
While Losartan is generally well tolerated, it can cause some severe side effects in rare instances. Be wary of symptoms such as:
- Signs of an allergic reaction, which include hives, itching, difficulty breathing or swallowing, swelling in your face or throat.
- Changes in urine output and color (indicating possible kidney issues).
- Light-headedness or fainting spells due to a sudden drop in blood pressure.
- Rapid heartbeat or palpitations.
- Severe gastrointestinal problems including stomach pain and persistent nausea/vomiting.
- Jaundice (yellowing of the skin/eyes) indicating liver problems.
If you experience any of these symptoms while taking Losartan, seek immediate medical attention.
Contraindications for Olmesartan and Losartan?
Both olmesartan and losartan, along with most other antihypertensive medications, may cause symptoms like dizziness or lightheadedness in some people. If you notice your symptoms worsening or feel faint after taking these drugs, please seek immediate medical attention.
Neither olmesartan nor losartan should be taken if you are taking, or have been taking angiotensin-converting enzyme (ACE) inhibitors. Always tell your physician which medications you are using; ACE inhibitors will require a period of about 2 weeks to clear from the system to prevent dangerous interactions with olmesartan and losartan.
How much do Olmesartan and Losartan cost?
For the brand name versions of these drugs:
- The price for 30 tablets of Olmesartan (20 mg) averages $125, which works out to approximately $4.15/day.
- A pack of 30 Losartan tablets (50 mg) has an average cost around $100, working out to roughly about $3.33/day.
Thus, if you are in a higher dosage range for Olmesartan (i.e., 40 mg/day or higher), then brand-name Losartan is less expensive on a per-day treatment basis. However, it should be noted that cost should not be the primary consideration in determining which medication is right for you.
In terms of generic versions:
-
Generic Olmesartan costs can vary widely depending on your location and provider but typically run between $10 and $40 for 30 tablets(20mg), this results in daily costs as low as $.33 up to about $1.35 per day.
-
Generic Losartan prices can also fluctuate greatly based on factors such as location, provider and insurance coverage but usually fall within a range from about $.11 up to around $.75 per tablet(50mg). This equates with a potential daily treatment cost ranging from $.11 up to approximately $.75
Popularity of Olmesartan and Losartan
Olmesartan and Losartan are both angiotensin II receptor blockers (ARBs) commonly prescribed for the treatment of high blood pressure, heart failure, and kidney disease from diabetes.
In 2020, Losartan was estimated to have been prescribed to about 37 million people in the US. It accounted for more than half of all ARB prescriptions that year. Being one of the first drugs in this class released on the market has likely contributed to its popularity. Furthermore, it is included in WHO's List of Essential Medicines due to its efficacy and cost-effectiveness.
On the other hand, Olmesartan was prescribed to approximately 5 million people in the USA during that same period. Although it represents a smaller share compared with Losartan, Olmesartan’s use has been gradually increasing since its introduction into clinical practice in early 2002 due to some studies suggesting potential advantages over other ARBs including longer duration of action and possibly superior blood pressure control.
Conclusion
Both Olmesartan and Losartan have established histories of use in patients with hypertension, with numerous clinical studies and meta-analyses indicating that they are more effective than placebo treatments. Both of these drugs belong to the class of angiotensin II receptor blockers (ARBs), working primarily by blocking the action of a hormone that causes blood vessels to narrow.
Olmesartan is usually considered when first-line ARBs like Losartan do not provide adequate blood pressure control or in cases where patients need additional cardiovascular risk reduction due to its superior ability to reduce systolic blood pressure.
Both medications are available as generics, which represents significant cost savings for out-of-pocket payers. It's also worth noting that both Olmesartan and Losartan may require an adjustment period, meaning that their full effects may not be noticeable right away.
The side effect profiles for both medicines are similar; however, Losartan tends to be slightly better tolerated with fewer instances of minor side effects such as dizziness or stomach discomfort. For both medications, it’s important for patients to monitor their blood pressure regularly and seek medical help immediately if they experience symptoms such as fainting spells, irregular heartbeat or swelling in the extremities.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Matsumura, K., Arima, H., Tominaga, M., Ohtsubo, T., Sasaguri, T., Fujii, K., … for the COMFORT Investigators. (2014, July 22). Effect of losartan on serum uric acid in hypertension treated with a diuretic: the COMFORT study. Clinical and Experimental Hypertension. Informa UK Limited.http://doi.org/10.3109/10641963.2014.933968
- Chilman-Blair, K., & Rabasseda, X. (2003). Olmesartan, an AT1-selective antihypertensive agent. Drugs of Today. Portico.http://doi.org/10.1358/dot.2003.39.10.799468
- Carr, A. A., & Prisant, L. M. (1996, January). Losartan: First of a New Class of Angiotensin Antagonists for the Management of Hypertension. The Journal of Clinical Pharmacology. Wiley.http://doi.org/10.1002/j.1552-4604.1996.tb04146.x
- Leifert, W. R., Bucco, O., Abeywardena, M. Y., & Patten, G. S. (2009). Radioligand Binding Assays: Application of [125I]Angiotensin II Receptor Binding. Methods in Molecular Biology. Humana Press.http://doi.org/10.1007/978-1-60327-317-6_9
- Wang, L., Zhao, J.-. wei ., Liu, B., Shi, D., Zou, Z., & Shi, X.-. yin. (2012, October). Antihypertensive Effects of Olmesartan Compared with Other Angiotensin Receptor Blockers. American Journal of Cardiovascular Drugs. Springer Science and Business Media LLC.http://doi.org/10.1007/bf03261842
- Hazan, L., Hernández Rodriguez, O. A., Bhorat, A. E., Miyazaki, K., Tao, B., & Heyrman, R. (2010, June). A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension. Hypertension. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1161/hypertensionaha.109.147702
- Fishman, T. J., Degu, T. A., Sun, L., & Salabei, J. K. (2019, December 13). Possible Association of Tremors and Dysarthria with Losartan Use: A Case Report. Cureus. Springer Science and Business Media LLC.http://doi.org/10.7759/cureus.6374
- Mann, R., Mackay, F., Pearce, G., Freemantle, S., & Wilton, L. (1999, July 27). Losartan: a study of pharmacovigilance data on 14 522 patients. Journal of Human Hypertension. Springer Science and Business Media LLC.http://doi.org/10.1038/sj.jhh.1000880
- Simons, W. R. (2003). Comparative Cost Effectiveness of Angiotensin II Receptor Blockers in a US Managed Care Setting. PharmacoEconomics. Springer Science and Business Media LLC.http://doi.org/10.2165/00019053-200321010-00005
- Omboni, S., & Volpe, M. (2018, November 13). Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan. Cardiovascular Therapeutics. Wiley.http://doi.org/10.1111/1755-5922.12471
- AGATA, J., URA, N., YOSHIDA, H., SHINSHI, Y., SASAKI, H., HYAKKOKU, M., … SHIMAMOTO, K. (2006). Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme. Hypertension Research. Japanese Society of Hypertension.http://doi.org/10.1291/hypres.29.865
- Moen, M. D., & Wagstaff, A. J. (2005). Losartan. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200565180-00012
- Sasaki, M., Fujimura, A., Harada, K., Sunaga, K., & Ebihara, A. (1996, May). Clinical Pharmacology of Multiple‐Dose Losartan, an Angiotensin II Receptor Antagonist, in Patients with Essential Hypertension. The Journal of Clinical Pharmacology. Wiley.http://doi.org/10.1002/j.1552-4604.1996.tb05026.x
- Scott, L. J., & McCormack, P. L. (2008). Olmesartan Medoxomil. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200868090-00005